Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Adv Skin Wound Care ; 29(7): 322-7, 2016 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-27300363

RESUMEN

OBJECTIVE: Angiogenesis is an important factor for flap viability. It has been reported that ozonated oil contributed to improved neovascularization in an acute cutaneous wound healing model. This study was undertaken to evaluate the effect of ozonated olive oil on vascular endothelial growth factor (VEGF)-mediated neovascularization of skin flaps in rats. STUDY DESIGN: A skin flap model was established in 21 rats and evaluated within 3 groups. No treatment was given to the rats in group 1. Olive oil and ozonated olive oil were topically applied (twice daily) to the flap surface for 7 days in groups 2 and 3, respectively. Immunohistochemical staining was performed to analyze the expressions of VEGF and CD34. RESULTS: The mean numbers of VEGF- and CD34-positive staining microvascular structures were 8.86 (SD, 1.35) and 10.29 (SD, 1.80) in group 1, 15.00 (SD, 1.41) and 15.57 (SD, 1.72) in group 2, and 25.14 (SD, 2.41) and 25.00 (SD, 2.16) in group 3. The VEGF and CD34 expressions in group 3 were significantly higher than those in group 2 (P < .001). Their expressions in group 2 were significantly higher than those in group 1 (P < .001). CONCLUSIONS: Both ozonated olive oil and olive oil improved neovascularization when they were topically applied on skin flaps. The effect of ozone was more prominent.


Asunto(s)
Neovascularización Fisiológica/efectos de los fármacos , Aceite de Oliva/administración & dosificación , Heridas y Lesiones/cirugía , Administración Tópica , Análisis de Varianza , Animales , Antígenos CD34/metabolismo , Biomarcadores/análisis , Intervalos de Confianza , Modelos Animales de Enfermedad , Masculino , Ozono , Fitoterapia/métodos , Distribución Aleatoria , Ratas , Ratas Wistar , Trasplante de Piel , Colgajos Quirúrgicos , Factor A de Crecimiento Endotelial Vascular/metabolismo , Heridas y Lesiones/tratamiento farmacológico
2.
Turk J Gastroenterol ; 25(4): 393-7, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25254521

RESUMEN

BACKGROUND/AIMS: This study aimed to assess the long-term (>12 months) efficacy of nonoperative treatment (antibiotic administration) in the management of uncomplicated acute appendicitis (AA). MATERIALS AND METHODS: We surveyed uncomplicated AA patients who elected to undergo nonoperative treatment between 2010 and 2012. A binary logistic regression analysis was performed to identify the critical predictors of recurrence. Age, gender, presence of appendicolith, and white blood cell count on admission were analyzed as possible predictors of recurrence. RESULTS: The median follow-up period of the study was 23 months. Twelve of 118 patients (10.2%) were diagnosed with recurrent appendicitis. Seven were retreated with the same antibiotic protocol and did not show further recurrence. The binary logistic regression analysis revealed statistical significance only for the presence of appendicolith [P=0.001, Exp (B)=0.058, B=-2.845]. Recurrence rate was lower in the presence of appendicolith. CONCLUSION: Nonoperative treatment of uncomplicated AA is an effective option. Recurrence is rare and it can be addressed efficiently with the administration of a second course of antibiotics. The presence of appendicolith should not discourage physicians from prescribing nonoperative treatment for patients with uncomplicated AA.


Asunto(s)
Antibacterianos/uso terapéutico , Apendicitis/tratamiento farmacológico , Enfermedad Aguda , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Ampicilina/administración & dosificación , Antibacterianos/administración & dosificación , Apendicitis/complicaciones , Ceftriaxona/administración & dosificación , Quimioterapia Adyuvante , Femenino , Estudios de Seguimiento , Humanos , Litiasis/complicaciones , Masculino , Metronidazol/administración & dosificación , Persona de Mediana Edad , Recurrencia , Factores de Riesgo , Sulbactam/administración & dosificación , Factores de Tiempo , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...